Margaret B. Allison

Margaret B. Allison

Auto-generated profile, based on publicly available information

Margaret B. Allison

Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston MA USA; Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Journal of Endocrinology
Verified
Journal Article
Open access
PDF file
MAMargaret B Allison
Margaret B Allison
MMMartin G Myers
Martin G Myers
Hypothalamic leptin action promotes negative energy balance and modulates glucose homeostasis, as well as serving as a permissive signal to the neuroendocrine axes that control growth and reproduction. Since the initial discovery of leptin 20 years ago, we have learned a great deal about the molecular mechanisms of leptin action. An important aspect of this has been the dissection of the cellular mechanisms of leptin signaling, and how specific leptin signals influence physiology. Leptin acts via the long form of the leptin receptor LepRb. LepRb activation and subsequent tyrosine phosphorylation recruits and activates multiple signaling pathways, including STAT transcription factors, SHP2 and ERK signaling, the IRS-protein/PI3Kinase pathway, and SH2B1. Each of these pathways controls specific aspects of leptin action and physiology. Important inhibitory pathways mediated by suppressor of cytokine signaling proteins and protein tyrosine phosphatases also limit physiologic leptin action. This review summarizes the signaling pathways engaged by LepRb and their effects on energy balance, glucose homeostasis, and reproduction. Particular emphasis is given to the multiple mouse models that have been used to elucidate these functions in vivo.

1 October 2014 in Cell Metabolism
Verified
Journal Article
Open access
GDGarron T. Dodd
Garron T. Dodd
AWAmy A. Worth
Amy A. Worth
NNNicolas Nunn
Nicolas Nunn
AKAaron K. Korpal
Aaron K. Korpal
DBDavid A. Bechtold
David A. Bechtold
SLSimon M. Luckman
Simon M. Luckman
Leptin is a critical regulator of metabolism, which acts on brain receptors (Lepr) to reduce energy intake and increase energy expenditure. Some of the cellular pathways mediating leptin's anorectic actions are identified, but those mediating the thermogenic effects have proven more difficult to decipher. We define a population of neurons in the dorsomedial hypothalamic nucleus (DMH) containing the RFamide PrRP, which is activated by leptin. Disruption of Lepr selectively in these cells blocks thermogenic responses to leptin and causes obesity. A separate population of leptin-insensitive PrRP neurons in the brainstem is required, instead, for the satiating actions of the gut-derived hormone cholecystokinin (CCK). Global deletion of PrRP (in a loxSTOPlox-PrRP mouse) results in obesity and attenuated responses to leptin and CCK. Cre-recombinase-mediated reactivation of PrRP in brainstem rescues the anorectic actions of CCK, but reactivation in the hypothalamus is required to re-establish the thermogenic effect of leptin.

1 April 2015 in Molecular Metabolism
Verified
Journal Article
Open access
MAMargaret B. Allison
Margaret B. Allison
CPChrista M. Patterson
Christa M. Patterson
MKMichael J. Krashes
Michael J. Krashes
BLBradford B. Lowell
Bradford B. Lowell
MMMartin G. Myers
Martin G. Myers
DODavid P. Olson
David P. Olson
Leptin acts via its receptor (LepRb) on multiple subpopulations of LepRb neurons in the brain, each of which controls specific aspects of energy balance. Despite the importance of LepRb-containing neurons, the transcriptome and molecular identity of many LepRb subpopulations remain undefined due to the difficulty of studying the small fraction of total cells represented by LepRb neurons in heterogeneous brain regions. Here we sought to examine the transcriptome of LepRb neurons directly and identify markers for functionally relevant LepRb subsets. We isolated mRNA from mouse hypothalamic and brainstem LepRb cells by Translating Ribosome Affinity Purification (TRAP) and analyzed it by RNA-seq (TRAP-seq). TRAP mRNA from LepRb cells was enriched for markers of peptidergic neurons, while TRAP-depleted mRNA from non-LepRb cells was enriched for markers of glial and immune cells. Genes encoding secreted proteins that were enriched in hypothalamic and brainstem TRAP mRNA revealed subpopulations of LepRb neurons that contained neuropeptide-encoding genes (including prodynorphin, Pdyn) not previously used as functional markers for LepRb neurons. Furthermore, Pdyn (cre) -mediated ablation of Lepr (flox) in Pdyn-expressing neurons (LepRb (Pdyn) KO mice) blunted energy expenditure to promote obesity during high-fat feeding. TRAP-seq of CNS LepRb neurons defines the LepRb neuron transcriptome and reveals novel markers for previously unrecognized subpopulations of LepRb neurons.

16 July 2013 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
ABAnnette J. Bergner
Annette J. Bergner
LSLincon Stamp
Lincon Stamp
DGDavid G. Gonsalvez
David G. Gonsalvez
MAMargaret B. Allison
Margaret B. Allison
DODavid P. Olson
David P. Olson
HYHeather Young
Heather Young

20 April 2014 in Nature Medicine
Verified
Journal Article
Closed access
LWLinyuan Wang
Linyuan Wang
DODarren Opland
Darren Opland
STSue Tsai
Sue Tsai
CLCynthia T Luk
Cynthia T Luk
SSStephanie A Schroer
Stephanie A Schroer
MWMinna Woo
Minna Woo

1 March 2007 in American Journal of Physiology-Endocrinology and Metabolism
Verified
Journal Article
Closed access
PDF file
MJMichael J. Jurczak
Michael J. Jurczak
ADArpad M. Danos
Arpad M. Danos
VRVictoria R. Rehrmann
Victoria R. Rehrmann
MAMargaret B. Allison
Margaret B. Allison
CGCynthia C. Greenberg
Cynthia C. Greenberg
MBMatthew J. Brady
Matthew J. Brady
Adipocytes express the rate-limiting enzymes required for glycogen metabolism and increase glycogen synthesis in response to insulin. However, the physiological function of adipocytic glycogen in vivo is unclear, due in part to the low absolute levels and the apparent biophysical constraints of adipocyte morphology on glycogen accumulation. To further study the regulation of glycogen metabolism in adipose tissue, transgenic mice were generated that overexpressed the protein phosphatase-1 (PP1) glycogen-targeting subunit (PTG) driven by the adipocyte fatty acid binding protein (aP2) promoter. Exogenous PTG was detected in gonadal, perirenal, and brown fat depots, but it was not detected in any other tissue examined. PTG overexpression resulted in a modest redistribution of PP1 to glycogen particles, corresponding to a threefold increase in the glycogen synthase activity ratio. Glycogen synthase protein levels were also increased twofold, resulting in a combined greater than sixfold enhancement of basal glycogen synthase specific activity. Adipocytic glycogen levels were increased 200- to 400-fold in transgenic animals, and this increase was maintained to 1 yr of age. In contrast, lipid metabolism in transgenic adipose tissue was not significantly altered, as assessed by lipogenic rates, weight gain on normal or high-fat diets, or circulating free fatty acid levels after a fast. However, circulating and adipocytic leptin levels were doubled in transgenic animals, whereas adiponectin expression was unchanged. Cumulatively, these data indicate that murine adipocytes are capable of storing far higher levels of glycogen than previously reported. Furthermore, these results were obtained by overexpression of an endogenous adipocytic protein, suggesting that mechanisms may exist in vivo to maintain adipocytic glycogen storage at a physiological set point.